Rxivist logo

Transcriptomic analysis of probable asymptomatic and symptomatic Alzheimer brains

By Hamel Patel, Angela K. Hodges, Charles Curtis, Sang Hyuck Lee, Claire Troakes, Richard JB Dobson, Stephen J Newhouse

Posted 29 Apr 2019
bioRxiv DOI: 10.1101/621912 (published DOI: 10.1016/j.bbi.2019.05.009)

Individuals with intact cognition and neuropathology consistent with Alzheimer's disease (AD) are referred to as asymptomatic AD (AsymAD). These individuals are highly likely to develop AD, yet transcriptomic changes in the brain which might reveal mechanisms for their AD vulnerability are currently unknown. Entorhinal cortex, frontal cortex, temporal cortex and cerebellum tissue from 27 control, 33 AsymAD and 52 AD human brains were microarray expression profiled. Differential expression analysis identified a significant increase of transcriptomic activity in the frontal cortex of AsymAD subjects, suggesting fundamental changes in AD may initially begin within the frontal cortex region prior to AD diagnosis. Co-expression analysis identified an overactivation of the brain glutamate-glutamine cycle, and disturbances in the brain energy pathways in both AsymAD and AD subjects, while connectivity of key hub genes in this network indicates a shift from an already increased cell proliferation in AsymAD subjects to stress response and removal of amyloidogenic proteins in AD subjects. This study provides new insight into the earliest biological changes occurring in the brain prior to the manifestation of clinical AD symptoms and provides new potential therapeutic targets for early disease intervention.

Download data

  • Downloaded 268 times
  • Download rankings, all-time:
    • Site-wide: 61,499 out of 94,912
    • In genetics: 3,396 out of 4,824
  • Year to date:
    • Site-wide: 53,316 out of 94,912
  • Since beginning of last month:
    • Site-wide: 44,100 out of 94,912

Altmetric data


Downloads over time

Distribution of downloads per paper, site-wide


PanLingua

Sign up for the Rxivist weekly newsletter! (Click here for more details.)


News